A Betrayal of Progress - Why UK Aid Cuts Threaten the Future of HIV Prevention

At a moment when medical science has brought us to the doorstep of ending the AIDS pandemic, we find ourselves facing a heartbreaking paradox. While we celebrate the breakthrough of Lenacapavir - a twice-yearly injectable that is the closest thing we have ever had to an HIV vaccine - the resources needed to deliver it are being stripped away.

In a recent op-ed for The Independent, Yvette Raphael shared her deep concerns regarding the UK government’s decision to cut £900 million in bilateral aid to Africa. As a woman living with HIV in South Africa, Raphael knows that these are not just abstract policy shifts; they are life-and-death decisions that dismantle decades of hard-won progress.

The Power of Lenacapavir

Lenacapavir represents a revolution in HIV prevention. In clinical trials conducted right here in South Africa and Uganda, the drug showed 100% efficacy among women and girls - a group that accounts for two-thirds of all new infections in sub-Saharan Africa. Because it is an injection given only every six months, it removes the daily burden of pills and the stigma that often prevents vulnerable women from seeking care.

The Threat of Disinvestment

Science has delivered, and African women made that science possible by participating in these trials. Yet, without sustained funding through organisations like Unitaid, this breakthrough risks staying on the shelves of high-income markets, far out of reach for those who need it most.

The UK’s Official Development Assistance (ODA) cuts threaten:

• Local Production: Efforts to produce generic Lenacapavir in South Africa to ensure affordability and supply.

• Clinic Access: Community testing sites and prevention outreach programs are already closing.

• Health Equity: We risk a "moral catastrophe" where the tools to end an epidemic exist, but are denied to the most marginalised due to political choice.

At APHA, we believe that political leadership must match the pace of scientific innovation. We cannot allow this historic opportunity to slip through our fingers.

Read the full article on The Independent here.